|
Volumn 305, Issue 13, 2011, Pages 1288-1289
|
Reducing door-to-needle time for tPA use remains an elusive goal in stroke care
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
TISSUE PLASMINOGEN ACTIVATOR;
FIBRINOLYTIC AGENT;
CEREBROVASCULAR ACCIDENT;
EMERGENCY CARE;
HEALTH CARE QUALITY;
HEALTH CARE SYSTEM;
HOSPITAL CARE;
HUMAN;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SHORT SURVEY;
THERAPY DELAY;
TREATMENT PLANNING;
ACUTE DISEASE;
HOSPITAL;
NOTE;
STANDARD;
STATISTICS;
STROKE;
TIME;
UNITED STATES;
ACUTE DISEASE;
FIBRINOLYTIC AGENTS;
GUIDELINE ADHERENCE;
HOSPITALS;
HUMANS;
STROKE;
TIME FACTORS;
TISSUE PLASMINOGEN ACTIVATOR;
UNITED STATES;
|
EID: 79953751465
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2011.378 Document Type: Short Survey |
Times cited : (12)
|
References (0)
|